Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children

Child's Nervous System

Volumn 19, Issue 12, 2003, Pages 818-823

  López Aguilar, Enrique ^a   Sepúlveda Vildósola, Ana Carolina ^a   Rivera Márquez, Hugo ^a   Cerecedo Díaz, Fernando ^a   Valdés Sánchez, Martha ^a   Delgado Huerta, Sandra ^a   Wanzke del Angel, Volkmar ^a   Ramón García, Guillermo ^a   Rodríguez Jiménez, Héctor ^a   Hernández Contreras, Isidro ^a   Santacruz Castillo, Enrique ^a   Romo Rubio, Hugo A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Astrocytoma; Carboplatin; Etoposide; Glioblastoma multiforme; ICE; Ifosfamide

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; EFLORNITHINE; ETOPOSIDE; IFOSFAMIDE; MESNA; NITROSOUREA; ONDANSETRON; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ARTICLE; ASTROCYTOMA; BRAIN STEM TUMOR; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; INTRACRANIAL TUMOR; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOTHERAPY; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; CARBOPLATIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; MALE; PROSPECTIVE STUDIES; RADIOTHERAPY; SURVIVAL RATE;

EID: 10744229346     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-003-0822-1     Document Type: Article

References (20)

1. Al-Mefty O, Al-Rodhaun HF (1987) Factors affecting survival of children with malignant gliomas. Neurosurgery 20:416-420
2. Bottom KS, Ashley DM, Friedman HS, Lougee DC (2000) Evaluation of preradiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme. Writing Committee for the Brain Tumor Center at Duke. J Neurooncol 46:151-156
3. Bouffet E, Jouvet A, Thiesse P, Sindou M (1998) Chemotherapy for aggressive or anaplastic high grade oligodendrogliomas and oligoastrocytomas: better than a salvage treatment. Br J Neurosurg 12:217-222
4. Chastagner P, Sommelet OD, Kalifa C, Brunat MM, Zucker JM, Domeocq F (1993) Phase II study of ifosfamide in childhood brain tumors. Med Pediatr Oncol 21:49-53
5. Fine HA, Dear KB, Loeffier JS (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585-2597
6. Finlay JL, Boyett JM, Yates AJ, et al (1995) Randomized phase III trial in childhood high grade astrocytomas comparing vincristine, lomustine and prednisone with the eight drugs in one day regimen. J Clin Oncol 113:112
7. Finlay JL, Goldman S, Wong MC, Cairo M (1996) Pilot study of high dose thiotepa and etoposide with autologous bone marrow rescue in children with recurrent CNS tumors. J Clin Oncol 14:2495-2505
8. Ganju MB, Jenkins RB, O'Fallon JR, Scheitauer BW, Ransom DT, Katsmann JA (1994) Prognostic factors in gliomas. Cancer 74:920-927
9. Genc M, Zorlu AF, Atahan IL (2000) Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas. Radiother Oncol 56:233-238
10. Gentet JC, Doz F, Bouffet E, Plantaz D, Roché H, Tron P, Kalifa C, et al (1994) Carboplatin and VP-16 in medulloblastoma: a phase II study of the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol 23:422-427
11. Heideman RL, Douglas EC, Krance RA (1993) High dose chemotherapy and autologous bone marrow rescue in newly diagnosed pediatric malignant gliomas. J Clin Oncol 11:1458-1465
12. Kovnar E, Horowitz M, Kun L (1991) Carboplatin and etoposide in the treatment of childhood malignant glioma. Neurology 41:410
13. Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner J, Chang SM, Kyritsis AP, Gleason MJ, Hess KR (2000) Phase III randomized study of postradiotherapy chemotherapy with α-difluoromethylornithine-procarbazine, N2(2-chloroethyl)-N′-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Clin Cancer Res 6:3878-3884
14. Long DM (1970) Capillary ultrastructure and the blood brain barrier in human malignant brain tumors. J Neurosurg 32:127-144
15. López-Aguilar E, Sepúlveda-Vildósola AC, Rivera-Márquez H, Cerecedo-Díaz F, Hernández-Contreras I, Ramón-García G, Diegopérez-Ramírez J, Santacruz-Castillo E (2000) Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study. Arch Med Res 31:186-190
16. Marchese MJ, Chang CH (1990) Malignant astrocytic gliomas in children. Cancer 65:2771-2778
17. Neuwelt EA, Howieson J, Frenkel EP (1986) Therapeutic efficacy of chemotherapy with drug delivery enhancement by blood brain barrier modification in glioblastoma. Neurosurgery 19:573-579
18. Pendergrass TW, Milstein JM, Geyer IR (1987) Eight drugs in one day chemotherapy for brain tumors. J Clin Oncol 5:122-131
19. Phuphanich S, Edwards M, Levin V (1987) Supratentorial malignant gliomas in childhood. Ann Neurol 22:355-364
20. Puchner MJ, Herrmann HD, Berger J, Cristante L (2001) Surgery, tamoxifen, carboplatin, and radiotherapy in the treatment of newly diagnosed glioblastoma patients. J Neurooncol 49:147-155